Cargando…
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
The holy grail for HIV vaccine development is an immunogen that elicits persisting antibodies with broad neutralizing activity against field strains of the virus. Unfortunately, very little progress has been made in finding or designing such immunogens. Using the SIV model, we have taken a markedly...
Autores principales: | Johnson, Philip R, Schnepp, Bruce C, Zhang, Jianchao, Connell, Mary J, Greene, Sean M, Yuste, Eloisa, Desrosiers, Ronald C, Clark, K Reed |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723177/ https://www.ncbi.nlm.nih.gov/pubmed/19448633 http://dx.doi.org/10.1038/nm.1967 |
Ejemplares similares
-
Protection against SIV in Rhesus Macaques Using Albumin and CD4-Based Vector-Mediated Gene Transfer
por: Spitsin, Sergei, et al.
Publicado: (2020) -
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys
por: Boopathy, Archana V., et al.
Publicado: (2023) -
Vaccine Protection Against Acquisition of Neutralization-Resistant SIV Challenges in Rhesus Monkeys
por: Barouch, Dan H., et al.
Publicado: (2012) -
Some Ideas Engendered by Recent Work on Malaria
por: Senior-White, Ronald
Publicado: (1926) -
Accelerated heterologous prime-boost adenovirus vector-based SIV vaccine in neonatal rhesus monkeys
por: Liu, J, et al.
Publicado: (2012)